Cocrystal Pharma, Inc. (COCP)
1.11
-0.04
(-3.06%)
USD |
NASDAQ |
Oct 05, 16:00
1.08
-0.03
(-2.70%)
Pre-Market: 08:33
Cocrystal Pharma Price to Book Value : 14.66 for Oct. 5, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 14.66 |
| October 02, 2026 | 15.12 |
| October 01, 2026 | 15.06 |
| September 30, 2026 | 15.19 |
| September 29, 2026 | 14.79 |
| September 28, 2026 | 15.98 |
| September 25, 2026 | 15.45 |
| September 24, 2026 | 15.19 |
| September 23, 2026 | 15.72 |
| September 22, 2026 | 15.72 |
| September 21, 2026 | 15.72 |
| September 18, 2026 | 15.98 |
| September 17, 2026 | 15.06 |
| September 16, 2026 | 15.06 |
| September 15, 2026 | 15.06 |
| September 14, 2026 | 15.45 |
| September 11, 2026 | 16.38 |
| September 10, 2026 | 16.25 |
| September 09, 2026 | 16.38 |
| September 08, 2026 | 15.59 |
| September 04, 2026 | 14.92 |
| September 03, 2026 | 14.92 |
| September 02, 2026 | 15.32 |
| September 01, 2026 | 14.79 |
| August 31, 2026 | 15.32 |
| Date | Value |
|---|---|
| August 28, 2026 | 14.53 |
| August 27, 2026 | 15.06 |
| August 26, 2026 | 14.79 |
| August 25, 2026 | 14.92 |
| August 24, 2026 | 14.66 |
| August 21, 2026 | 15.19 |
| August 20, 2026 | 15.45 |
| August 19, 2026 | 15.12 |
| August 18, 2026 | 14.26 |
| August 17, 2026 | 14.40 |
| August 14, 2026 | 14.79 |
| August 13, 2026 | 14.53 |
| August 12, 2026 | 14.79 |
| August 11, 2026 | 14.26 |
| August 10, 2026 | 14.26 |
| August 07, 2026 | 14.00 |
| August 06, 2026 | 13.60 |
| August 05, 2026 | 13.47 |
| August 04, 2026 | 12.95 |
| August 03, 2026 | 12.42 |
| July 31, 2026 | 10.83 |
| July 30, 2026 | 11.46 |
| July 29, 2026 | 11.49 |
| July 28, 2026 | 12.35 |
| July 27, 2026 | 12.13 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.8665 |
| Fulcrum Therapeutics, Inc. | 0.9109 |
| Definium Therapeutics, Inc. | 5.299 |
| LeonaBio, Inc. | 1.565 |
Price to Book Value Related Metrics
| PS Ratio | 44.02 |
| Price | 1.11 |
| Earnings Yield | -68.35% |
| Market Cap | 15.31M |